Appraising the holistic value of Lenvatinib for radio-iodine refractory differentiated thyroid cancer: A multi-country study applying pragmatic MCDA

Appraising the holistic value of Lenvatinib for radio-iodine refractory differentiated thyroid cancer: A multi-country study applying pragmatic MCDA

Abstract Background The objective of the study was to reveal through pragmatic MCDA (EVIDEM) the contribution of a broad range of criteria to the value of the orphan drug lenvatinib for radioiodine refractory differentiated thyroid cancer (RR-DTC) in country-specific contexts. Methods The study was...

Full description

Bibliographic Details
Main Authors: Monika Wagner, Hanane Khoury, Liga Bennetts, Patrizia Berto, Jenifer Ehreth, Xavier Badia, Mireille Goetghebeur
Format: Article
Language:English
Published: BMC 2017-04-01
Series:BMC Cancer
Subjects:
Mcda
Appraisal
Healthcare decisionmaking
Lenvatinib
Online Access:http://link.springer.com/article/10.1186/s12885-017-3258-9

Internet

http://link.springer.com/article/10.1186/s12885-017-3258-9

Similar Items